Targeting Protein Kinase C: New Therapeutic Opportunities Against High-Grade Malignant Gliomas?

Targeting Protein Kinase C: New Therapeutic Opportunities Against High-Grade Malignant Gliomas? A. B. da Rocha, D.R.A. Mans, A. Regner, G. Schwartsmann Oncologist 2002; 7: 17-33 Author Information and Disclosures Target Audience: Physicians who wish to advance their current knowledge of clinical cancer medicine in clinical pharmacology and are involved in providing patient care in a cancer care environment. Method of Physician Participation: Read course materials, complete course quiz and evaluation form (optional). Learning Objectives After completing this course, the reader should be able to: Understand protein kinase C (PKC) in signal transduction pathways. Understand protein kinase C (PKC) in tumor cell proliferation and invasion. Understand protein kinase C as a potential target in experimental therapies for malignant gliomas. The NIH/FAES designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CME Activity Information Accreditation CME Instructions For Credit Privacy Statement Hardware/Software Requirements Release Date: Feb. 14, 2002 Most Recent Review: Nov. 15, 2005* Most Recent Update: Feb. 14, 2002 Date Credit Expires: Apr. 10, 2007 Time to Complete: 1 hour Medium: Internet Online *Click here to learn more about our review process.